What was Merck & Co., Inc.'s net income in 2018?

Merck & Co., Inc. reported $42.3B in revenue for fiscal year 2018. Merck opened this window with about 42.3 billion USD in net sales, a base built on its oncology franchise and vaccines as Keytruda began scaling across new cancer indications.

FY2018 Revenue

$42.3B

Net Income: $6.2B

Source: 10-K

Merck & Co., Inc. reported $42.3B in revenue for fiscal year 2018. In 2019, revenue increased to $46.8B.

Merck opened this window with about 42.3 billion USD in net sales, a base built on its oncology franchise and vaccines as Keytruda began scaling across new cancer indications.

Revenue by Year

FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018

Merck & Co., Inc. Annual Revenue History

Year	Revenue	Net Income	YoY Change
FY2025	$65.0B	—	+2.2%
FY2024	$63.6B	$17.1B	+5.8%
FY2023	$60.1B	$365M	+1.4%
FY2022	$59.3B	$14.5B	+21.7%
FY2021	$48.7B	$13.0B	+1.5%
FY2020	$48.0B	$7.1B	+2.5%
FY2019	$46.8B	$9.8B	+10.7%
FY2018	$42.3B	$6.2B	—

Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.

Next year →

FY2019: $46.8B

Explore Merck & Co., Inc.

Core profile pages, annual revenue records, and related research hubs for this company.